Janus Henderson Funds > JANUS INVESTMENT FUND
Janus Henderson Global Life Sciences Fund
$4.62B
Avg Monthly Net Assets
$5.48B
Total Assets
$5.20M
Total Liabilities
$5.47B
Net Assets
Janus Henderson Global Life Sciences Fund is a Mutual Fund in JANUS INVESTMENT FUND
from Janus Henderson Funds,
based in Colorado,
United States of America.
The fund has seven share classes
and monthly net assets of $4.62B.
On August 29th, 2024 it reported 117 holdings, the largest
being Eli Lilly & Co. (9.4%), UnitedHealth Group Inc. (6.1%) and Novo Nordisk A/S (5.9%).
Data provided by Fincoded.
Share Classes
| Name | Class/Contract ID | Ticker | Monthly Returns (2 years) |
|---|---|---|---|
| Class A Shares | C000077752 | JFNAX | |
| Class C Shares | C000077753 | JFNCX | |
| Class D Shares | C000083538 | JNGLX | |
| Class I Shares | C000077754 | JFNIX | |
| Class N Shares | C000198286 | JFNNX | |
| Class S Shares | C000077755 | JFNSX | |
| Class T Shares | C000028956 | JAGLX |
Holdings
From latest NPORT-P, filed August 29th, 2024 for period ending June 30th, 2024.
Historic holdings data available from Fincoded.
| Name | Profile | Category | Country | Value $USD | # Shares | % of Fund |
|---|---|---|---|---|---|---|
| 4D Molecular Therapeutics Inc COM | Long | Equity-common | US | $21M | 1M | 0.39 |
| 89bio Inc. COM | Long | Equity-common | US | $24M | 3M | 0.44 |
| Abbott Laboratories COM NPV | Long | Equity-common | US | $117M | 1M | 2.13 |
| AbbVie Inc. COM USD0.01 | Long | Equity-common | US | $202M | 1M | 3.68 |
| Akero Therapeutics Inc COM USD0.0001 | Long | Equity-common | US | $50M | 2M | 0.91 |
| Align Technology Inc. COM USD0.0001 | Long | Equity-common | US | $17M | 70K | 0.31 |
| Alnylam Pharmaceuticals Inc. COM USD0.01 | Long | Equity-common | US | $24M | 98K | 0.43 |
| Amgen Inc. COM USD0.0001 | Long | Equity-common | US | $170M | 544K | 3.11 |
| Amicus Therapeutics Inc. COM STK USD0.01 | Long | Equity-common | US | $22M | 2M | 0.40 |
| Arbor Biotechnologies Inc | Long | Equity-preferred | US | $1M | 156K | 0.02 |
| Arcellx Inc COMMON STOCK | Long | Equity-common | US | $27M | 490K | 0.49 |
| Ardelyx Inc COM USD0.0001 | Long | Equity-common | US | $37M | 5M | 0.68 |
| Argenx SE SPON ADR EACH REP 1 ORD SHS | Long | GDR | US | $94M | 218K | 1.72 |
| Ascendis Pharma A/S SPON ADR EACH REP 1 ORD SHS | Long | GDR | US | $68M | 500K | 1.25 |
| Asher Biotherapeutics - Series C (Asher Biotherapeutics Inc) | Long | Equity-preferred | US | $3M | 3M | 0.05 |
| Asher Biotherapeutics Inc | Long | Equity-preferred | US | $1M | 1M | 0.03 |
| AstraZeneca PLC ORD USD0.25 | Long | Equity-common | GB | $206M | 1M | 3.76 |
| Attralus Inc | Long | Equity-preferred | US | $5M | 670K | 0.09 |
| Avadel Pharmaceuticals PLC COM SHS | Long | Equity-common | US | $41M | 3M | 0.75 |
| Avidity Biosciences Inc. COM | Long | Equity-common | US | $35M | 868K | 0.65 |
| Bicara Therapeutics - Series C (Bicara Therapeutics Inc) | Long | Equity-preferred | US | $6M | 4M | 0.10 |
| Biohaven Ltd COM NPV | Long | Equity-common | US | $41M | 1M | 0.75 |
| Boston Scientific Corporation COM USD0.01 | Long | Equity-common | US | $132M | 2M | 2.42 |
| Bridgebio Pharma Inc | Long | Equity-common | US | $9M | 356K | 0.16 |
| Bridgebio Pharma Inc COM USD0.001 | Long | Equity-common | US | $13M | 523K | 0.24 |
| CARGO Therapeutics Inc. COM | Long | Equity-common | US | $9M | 552K | 0.17 |
| Catalyst Pharmaceuticals Inc. COM STK USD0.001 | Long | Equity-common | US | $10M | 625K | 0.18 |
| Cencora Inc COM USD0.01 | Long | Equity-common | US | $82M | 363K | 1.49 |
| Centene Corporation COM USD0.001 | Long | Equity-common | US | $32M | 480K | 0.58 |
| CG Oncology Inc. COM | Long | Equity-common | US | $10M | 306K | 0.18 |
| Clementia Pharmaceuticals Inc COM | Long | Rights | US | $0.87 | 874K | 0.00 |
| Crinetics Pharmaceuticals Inc. COM USD0.001 | Long | Equity-common | US | $21M | 462K | 0.38 |
| Curevo Inc (Green Cross Holdings Corp) | Long | Equity-preferred | US | $6M | 2M | 0.10 |
| Cytokinetics Inc COM USD0.001 | Long | Equity-common | US | $22M | 403K | 0.40 |
| Danaher Corporation COM USD0.01 | Long | Equity-common | US | $96M | 382K | 1.74 |
| Dentsply Sirona Inc COM USD0.01 | Long | Equity-common | US | $14M | 543K | 0.25 |
| DexCom Inc COM USD0.001 | Long | Equity-common | US | $25M | 225K | 0.47 |
| Dyne Therapeutics Inc. COM | Long | Equity-common | US | $42M | 1M | 0.77 |
| Edwards Lifesciences Corporation COM USD1 | Long | Equity-common | US | $76M | 822K | 1.39 |
| Element Biosciences Inc | Long | Equity-preferred | US | $5M | 425K | 0.10 |
| Elevance Health Inc. COM USD0.01 | Long | Equity-common | US | $87M | 160K | 1.58 |
| Eli Lilly & Co. COM NPV | Long | Equity-common | US | $513M | 567K | 9.37 |
| Freenome Holdings Inc - Series C | Long | Equity-preferred | US | $2M | 337K | 0.03 |
| Freenome Holdings Inc - Series D | Long | Equity-preferred | US | $2M | 343K | 0.03 |
| Gilead Sciences, Inc. COM USD0.001 | Long | Equity-common | US | $18M | 258K | 0.32 |
| Globus Med Inc COM USD0.001 CL 'A' | Long | Equity-common | US | $62M | 898K | 1.12 |
| HCA Healthcare Inc COM USD0.01 | Long | Equity-common | US | $66M | 206K | 1.21 |
| HeartFlow Inc - Series F | Long | Equity-preferred | US | $6M | 2M | 0.11 |
| HemoShear Therapeutics LLC | Long | Equity-preferred | US | $0.29 | 289K | 0.00 |
| HOYA Corp. NPV | Long | Equity-common | JP | $26M | 226K | 0.48 |
| Humana Inc. COM USD0.166 | Long | Equity-common | US | $68M | 183K | 1.25 |
| Icon PLC ORD EUR0.06 | Long | Equity-common | US | $26M | 81K | 0.47 |
| IDEAYA Biosciences Inc. COM USD0.0001 | Long | Equity-common | US | $25M | 720K | 0.46 |
| Illumina Inc COM USD0.01 | Long | Equity-common | US | $25M | 236K | 0.45 |
| Immunome Inc COM | Long | Equity-common | US | $10M | 797K | 0.18 |
| INSM 0.75 06/01/28 (Insmed Inc) | Long | Debt | US | $16M | – | 0.29 |
| Insmed Inc COM USD0.01 | Long | Equity-common | US | $27M | 400K | 0.49 |
| Inspire Medical Systems Inc COM USD0.001 | Long | Equity-common | US | $21M | 154K | 0.38 |
| Intuitive Surgical Inc. COM USD0.001 | Long | Equity-common | US | $82M | 185K | 1.50 |
| IQVIA Holdings Inc. COM USD0.01 | Long | Equity-common | US | $12M | 59K | 0.23 |
| Janus Henderson Cash Collateral Fund | Long | Equity-common | US | $7M | 7M | 0.13 |
| Janus Henderson Cash Liquidity Fund LLC (JANUS CAPITAL GROUP INC) | Long | Equity-common | US | $23M | 23M | 0.42 |
| Janux Therapeutics Inc COM | Long | Equity-common | US | $19M | 446K | 0.34 |
| Johnson & Johnson COM USD1.00 | Long | Equity-common | US | $33M | 225K | 0.60 |
| Lantheus Holdings Inc COM USD0.01 | Long | Equity-common | US | $43M | 536K | 0.79 |
| Legend Biotech Corporation SPONSORED ADS | Long | GDR | US | $24M | 536K | 0.43 |
| Lexeo Therapeutics Inc COM | Long | Equity-common | US | $12M | 770K | 0.23 |
| Madrigal Pharmaceuticals Inc USD0.0001 | Long | Equity-common | US | $72M | 256K | 1.31 |
| Magnolia Medical Technologies | Long | Equity-preferred | US | $3M | 2M | 0.05 |
| Magnolia Medical Technologies (Hemoshear Therapeutics LLC) | Long | Debt | US | $192K | – | 0.00 |
| Magnolia Medical Technologies | Long | Equity-common | US | $0 | 1 | – |
| Medtronic PLC USD0.0001 | Long | Equity-common | US | $33M | 418K | 0.60 |
| Merck & Co., Inc COM USD0.50 | Long | Equity-common | US | $180M | 1M | 3.28 |
| Merus B V EUR0.09 | Long | Equity-common | US | $11M | 182K | 0.20 |
| Mirum Pharmaceuticals Inc. COM USD0.0001 | Long | Equity-common | US | $33M | 958K | 0.60 |
| Neogenomics Inc COM NPV | Long | Equity-common | US | $15M | 1M | 0.27 |
| Neurocrine Biosciences Inc COM USD0.001 | Long | Equity-common | US | $28M | 201K | 0.51 |
| Neurogene Inc | Long | Equity-common | US | $4M | 115K | 0.08 |
| Neurogene Inc - Series B | Long | Equity-common | US | $5M | 128K | 0.09 |
| Neurogene Inc. COM | Long | Equity-common | US | $4M | 99K | 0.07 |
| New Horizon Health Limited USD0.00005 | Long | Equity-common | HK | $10M | 8M | 0.17 |
| Novartis AG ADR-REP 1 CHF0.5 (REGD) | Long | GDR | US | $121M | 1M | 2.21 |
| Novo Nordisk A/S SER'B'DKK0.1 | Long | Equity-common | DK | $326M | 2M | 5.95 |
| Penumbra Inc. COM USD0.001 | Long | Equity-common | US | $22M | 123K | 0.40 |
| Perspective Therapeutics Inc COM NEW | Long | Equity-common | US | $9M | 924K | 0.17 |
| Prothena Corporation PLC USD0.01 | Long | Equity-common | US | $9M | 443K | 0.17 |
| PTC Therapeutics, Inc. COM USD0.001 | Long | Equity-common | US | $32M | 1M | 0.59 |
| Regeneron Pharmaceuticals, Inc. COM USD0.001 | Long | Equity-common | US | $37M | 35K | 0.67 |
| Revolution Medicines Inc COM | Long | Equity-common | US | $33M | 857K | 0.61 |
| Rhythm Pharmaceuticals Inc COM USD0.001 | Long | Equity-common | US | $12M | 287K | 0.22 |
| Roche Holdings AG GENUSSCHEINE NPV | Long | Equity-preferred | CH | $59M | 213K | 1.08 |
| Rocket Pharmaceuticals Inc COM USD0.01 | Long | Equity-common | US | $12M | 541K | 0.21 |
| Royal Bank of Canada | Long | Short-term investment vehicle | US | $2M | – | 0.03 |
| Royalty Pharma PLC COM USD0.0001 CLASS A | Long | Equity-common | US | $20M | 752K | 0.36 |
| Sanofi EUR2 | Long | Equity-common | FR | $134M | 1M | 2.45 |
| Sarepta Therapeutics Inc COM USD0.0001 | Long | Equity-common | US | $104M | 657K | 1.90 |
| Shoreline Biosciences Inc | Long | Equity-preferred | US | $6M | 747K | 0.10 |
| Soleno Therapeutics Inc COM | Long | Equity-common | US | $24M | 578K | 0.43 |
| Sonoma Biotherapeutics Inc - Series B | Long | Equity-preferred | US | $4M | 1M | 0.08 |
| Sonoma Biotherapeutics Inc - Series B-1 | Long | Equity-preferred | US | $2M | 669K | 0.04 |
| Sotera Health Company COM | Long | Equity-common | US | $17M | 1M | 0.31 |
| Steris PLC ORD USD0.001 | Long | Equity-common | US | $32M | 146K | 0.59 |
| Structure Therapeutics Inc SPONSORED ADS | Long | GDR | US | $27M | 679K | 0.49 |
| Stryker Corporation COM USD0.10 | Long | Equity-common | US | $100M | 293K | 1.82 |
| Takeda Pharmaceutical Co Ltd. NPV | Long | Equity-common | JP | $16M | 613K | 0.29 |
| Tandem Diabetes Care Inc COM USD0.001(POST REV SPLT) | Long | Equity-common | US | $10M | 242K | 0.18 |
| Teleflex Incorporated COM USD1 | Long | Equity-common | US | $35M | 167K | 0.64 |
| The Cooper Companies, Inc. COM | Long | Equity-common | US | $34M | 384K | 0.61 |
| Thermo Fisher Scientific Inc COM USD1 | Long | Equity-common | US | $102M | 184K | 1.86 |
| TwinStrand Biosciences Inc | Long | Equity-preferred | US | $1M | 344K | 0.03 |
| United Therapeutics Corporation COM USD0.01 | Long | Equity-common | US | $49M | 155K | 0.90 |
| UnitedHealth Group Inc. COM USD0.01 | Long | Equity-common | US | $335M | 658K | 6.13 |
| Vaxcyte Inc COM | Long | Equity-common | US | $74M | 981K | 1.35 |
| Vertex Pharmaceuticals Incorporated COM USD0.01 | Long | Equity-common | US | $129M | 275K | 2.35 |
| Xenon Pharmaceuticals Inc COM NPV | Long | Equity-common | US | $10M | 249K | 0.18 |
| Zai Lab Ltd. ADS EACH REP 1 ORD SHS | Long | GDR | US | $28M | 2M | 0.50 |
| Zoetis Inc. COM USD0.01 CL 'A' | Long | Equity-common | US | $42M | 244K | 0.77 |
Address
JANUS INVESTMENT FUND
151 DETROIT STREET
DENVER
Colorado
80206
United States of America
Directors
William F. McCalpin
Alan A. Brown
William D. Cvengros
Raudline Etienne
Gary A. Poliner
Diane L. Wallace
Cheryl D. Alston
Darrell B. Jackson
Transfer Agents
JANUS HENDERSON SERVICES US LLC
Pricing Services
Refinitiv US Holdings Inc.
Virtu ITG LLC
PricingDirect Inc.
ICE Data Pricing & Reference Data, LLC
Bloomberg Finance L.P.
Markit North America, Inc
Custodians
BNP Paribas Securities Services, Athens Branch
Clearstream Banking AG
CLEARSTREAM BANKING SA
Depository Trust and Clearing Corporation
DTCC
Federal Reserve Bank
HSBC BANK BERMUDA LIMITED
HSBC Bank Egypt SAE
MIZUHO BANK, LTD
Skandinaviska Enskilda Banken AS, Helsinki
Skandinaviska Enskilda Banken AB
Skandinaviska Enskilda Banken AS, Oslo
BNP Paribas Securities Services SCA, Australia Branch
BNP PARIBAS SECURITIES SERVICES SCA, Paris
Banco BNP Paribas Brasil SA
CIBC Mellon Global Securities Services Company
Bank Leumi LE-ISRAEL B.M.
HSBC Mexico SA
Standard Chartered Bank Korea Limited
BNP Paribas Securities Services SCA Singapore Branch
BNP Paribas Securities Services Zurich Branch
Standard Chartered Bank Taiwan Limited
BNP Paribas Securities Services SCA, London Branch
BNP Paribas New York Branch
BNP Paribas Securities Services SCA, Hong Kong Branch
Standard Chartered Bank, Johannesburg Branch
BNP Paribas Securities Services SCA, Milan Branch
BNP Paribas Securities Services S.C.A.,Frankfurt branch
Standard Chartered Bank
Standard Chartered Bank
Dansek Bank A/S
Shareholder Servicing Agents
JANUS HENDERSON SERVICES US LLC
Admins
JANUS HENDERSON INVESTORS US LLC
BNP Paribas Financial Services LLC
Brokers
Jefferies LLC
Goldman Sachs & Co. LLC
Merrill Lynch, Pierce, Fenner & Smith Inc.
Cowen and Company
JP Morgan Securities LLC
Morgan Stanley
Liquidnet, Inc.
Citigroup Global Markets Inc.
UBS Securities LLC
William Blair & Company, LLC